| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.88▲ | 2.86▲ | 2.86▲ | 2.92▼ | 2.02▲ |
| MA10 | 2.86▲ | 2.87▲ | 2.87▲ | 3.03▼ | 1.49▲ |
| MA20 | 2.90▼ | 2.90▼ | 2.90▼ | 1.96▲ | 1.83▲ |
| MA50 | 2.99▼ | 2.96▼ | 2.72▲ | 1.48▲ | 3.04▼ |
| MA100 | 2.09▲ | 1.80▲ | 1.69▲ | 1.86▲ | 17.03▼ |
| MA200 | 1.40▲ | 1.47▲ | 1.59▲ | 2.40▲ | 110.05▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.022▼ | -0.031▼ | 0.084▲ | 0.409▲ |
| RSI | 49.864▼ | 51.964▲ | 53.351▲ | 67.844▲ | 53.379▲ |
| STOCH | 70.737 | 37.646 | 32.106 | 46.104 | 38.999 |
| WILL %R | -22.581▲ | -57.143 | -57.143 | -26.664 | -26.664 |
| CCI | 30.150 | -17.758 | 4.536 | 24.065 | 102.320▲ |
|
Thursday, August 13, 2026 01:15 PM
Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal first quarter ended June 30, 2026, and ...
|
|
Wednesday, July 29, 2026 05:00 PM
Detailed price information for Aethlon Medical Inc (AEMD-Q) from The Globe and Mail including charting and trades.
|
|
Sunday, July 12, 2026 07:22 PM
(MENAFN- Investor Ideas) newswire), a leading investing news platform and biotech-stock research destination, features clinical-stage medical technology company and Investorideas featured stock ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/08/26 | 2.94 | 2.9499 | 2.76 | 2.89 | 33,311 |
| 17/08/26 | 2.8908 | 3.06 | 2.87 | 2.935 | 58,851 |
| 14/08/26 | 2.93 | 3.05 | 2.78 | 2.83 | 37,668 |
| 13/08/26 | 3.05 | 3.105 | 2.92 | 2.93 | 19,940 |
| 12/08/26 | 3.09 | 3.09 | 2.91 | 3.04 | 26,499 |
| 11/08/26 | 3.105 | 3.20 | 3.10 | 3.18 | 15,535 |
| 10/08/26 | 3.13 | 3.13 | 3.00 | 3.08 | 14,253 |
| 07/08/26 | 3.0937 | 3.27 | 3.00 | 3.15 | 72,888 |
| 06/08/26 | 3.23 | 3.3899 | 2.995 | 3.02 | 69,884 |
| 05/08/26 | 3.52 | 3.70 | 3.21 | 3.25 | 151,320 |
|
|
||||
|
|
||||
|
|